Ameloblastic carcinoma of the maxillary sinus.

Anticancer Res

Università degli Studi di Milano-Bicocca, Facoltà di Medicina e Chirurgia, Sezione Anatomia Patologica, Ospedale San Gerardo, Monza, Mi, Italy.

Published: February 2009

Ameloblastic carcinoma is a very rare malignant odontogenic neoplasm of the mandible and maxilla, accounting for some 66 reported cases. The case of a 68-year-old man who presented a fistula with orosinus communication of 14-year duration that, after anti-aggregant therapy, began bleeding is reported. The initial microscopic evaluation of the biopsy and radiographic findings were consistent with benign peripheral ameloblastoma without cellular atypia and extensive fields of acantomatous pattern, but immunohistochemical investigation found strong positivity for Bcl-2, cytokeratins CAM 5 and 6, and for Ki-67/MIB-1, changing our diagnosis. The treatment consisted of left maxillary resection followed by reconstruction. Cellular features of malignancy in the surgical specimen confirmed the diagnosis of ameloblastic carcinoma. This case of an aggressive ameloblastic carcinoma of the maxillary gingiva that presented with an unusual histological pattern illustrates that these tumors can create a diagnostic challenge that may require extensive surgical sampling and/or removal to establish the diagnosis. Immunohistochemically analyzed expression of bcl-2 protein, cytokeratins CAM 5 and 6, and Ki-67/MIB-1 antigen serve to characterize the cyto-differentiation and cellular activity of ameloblastic carcinoma.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ameloblastic carcinoma
20
carcinoma maxillary
8
cytokeratins cam
8
cam ki-67/mib-1
8
ameloblastic
5
maxillary sinus
4
sinus ameloblastic
4
carcinoma
4
carcinoma rare
4
rare malignant
4

Similar Publications

Difference in survival and prognosis between malignant tumors of odontogenic origin.

J Stomatol Oral Maxillofac Surg

November 2024

Sorbonne Université, Paris, France; Department of Maxillo-Facial Surgery, Hôpital Pitié-Salpêtrière, Assistance Publique des Hôpitaux de Paris, Paris, France; Sorbonne université, INSERM UMRS 938, Centre de Recherche de Saint Antoine, Team Cancer Biology and Therapeutics, France.

Introduction: The prognosis of metastatic ameloblastoma (METAM), now defined as a benign tumor, and malignant odontogenic tumors (MOT) is poorly studied in the literature. The aim of this study was to determine the prognosis and factors influencing the survival of these patients.

Material And Methods: Using the SEER database, we retrieved clinical data of patients with malignant tumors of dental origin between 1975 and 2020.

View Article and Find Full Text PDF

Surrogate Immunohistochemical Markers of Proliferation and Embryonic Stem Cells in Distinguishing Ameloblastoma from Ameloblastic Carcinoma.

Head Neck Pathol

October 2024

Department of Oral and Maxillofacial Pathology, Faculty of Health Sciences, University of Pretoria, Pretoria Oral Health Care Centre, Office 6-11, Corner of Steve Biko and Dr Savage Roads, Pretoria, 0084, South Africa.

Purpose: The current study aimed to investigate the use of surrogate immunohistochemical (IHC) markers of proliferation and stem cells to distinguish ameloblastoma (AB) from ameloblastic carcinoma (AC).

Methods: The study assessed a total of 29 ACs, 6 ABs that transformed into ACs, and a control cohort of 20 ABs. The demographics and clinicopathologic details of the included cases of AC were recorded.

View Article and Find Full Text PDF
Article Synopsis
  • The research analyzed the occurrence of odontogenic tumors (OT) and certain cysts at an oral pathology center in New Zealand over 15 years, revealing that 1.8% of biopsies were identified as these conditions.
  • The most common types identified were odontoma, ameloblastoma, and cemento-ossifying fibroma, with male patients and those diagnosed in the mandibular region being more prevalent.
  • The study highlighted the importance of long-term monitoring for patients with OKC and ameloblastoma due to their recurrence rates of 15.2% and 13.7%, respectively.
View Article and Find Full Text PDF

Background: Differentiating between ameloblastoma (AB) and ameloblastic carcinoma (AC) is difficult, especially when AB has atypical cytological characteristics or an uncommon clinical history. This systematic review and meta-analysis aimed to elucidate the differential expression of immunohistochemical markers between AB and AC.

Methods: We conducted a thorough search of PUBMED and SCOPUS according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to identify cross-sectional studies that compared the expression of immunohistochemical markers in AB and AC.

View Article and Find Full Text PDF
Article Synopsis
  • Ameloblastoma is a benign but aggressive tumor linked to teeth, and the study investigates the potential connection between this tumor and high-risk human papillomavirus (HPV) types, particularly because HPV is known to influence other oral cancers.
  • DNA was extracted from tissue samples, and the presence of 14 HPV types was tested using advanced PCR techniques, while also collecting data on patients' demographics and lifestyle factors.
  • The study found HPV 16 in two conventional ameloblastoma cases, with no correlation between HPV positivity and factors like smoking or alcohol, suggesting that HPV has a limited role in the development of ameloblastoma.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!